Anti-CLDN18.2 Antibody (Zolbetuximab)
Catalog No.
F1492
Anti-CLDN18.2 Antibody (Zolbetuximab)
Featured Products
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab specifically kills Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used in the study of gastrointestinal adenocarcinoma and pancreatic tumors.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
1496553-00-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IMAB-362, IMAB 362, GC-182
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P56856
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CLDN18.2 VLP at 2 ug/mL can bind Anti-CLDN18.2 Antibody (Zolbetuximab)
CLDN18.2
Please avoid freeze-thaw cycles.